The Biden administration on Thursday asserted its authority to seize the patents of certain costly medications in a new push to slash high drug prices and promote more pharmaceutical competition.

The administration unveiled a framework outlining the factors federal agencies should consider in deciding whether to use a controversial policy, known as march-in rights, to break the patents of drugs that were developed with federal funds but are not widely accessible to the public. For the first time, officials can now factor in a medication’s price — a change that could have big implications for drugmakers depending on how the government uses the powers.

“When drug companies won’t sell taxpayer-funded drugs at reasonable prices, we will be prepared to allow other companies to provide those drugs for less,” White House National Economic Advisor Lael Brainard said during a call with reporters Wednesday.

  • @[email protected]
    link
    fedilink
    41 year ago

    I’m in the US and generally don’t watch live TV with commercials, but when I do, good god the pharmaceutical commercials!

    • @[email protected]
      link
      fedilink
      81 year ago

      I only usually watch TV for sports games… that being said, the new enemy is gambling commercials.

      Good fucking God they’re predatory